Sweet Syndrome Flashcards

1
Q

Compare the classic clinical presentation with other sweet variants

A

Classic : Pink/ erythymatous edematous papules and plaque, might enlarge and coalesce. surface might appear mamillated/ pseudopustular/ pseudovesicular due to edema.

Other possible features
* vesicles
* pustules
* vesiculobullous variant, which is most frequently associated with acute myelogenous
Leukemia, can progress to ulceration resembling superficial pyoderma gangrenosum (PG). In this form, there may be a single lesion or multiple, asymmetrically distributed lesions.
* ulcers - might appear like superficial PG.

  • targetoid appearance with central yellowish discoloration.
  • A facial erysipelas-like appearance.
  • giant cellulitis-like variant.
  • Papulonodules involving the lower legs may resemble erythema nodosum.When isolated, the latter is often referred to as subcutaneous Sweet syndrome.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Compare the classic clinical presentation with other sweet variants

A

TENDER NON -pruritic Pink/ erythymatous edematous papules and plaque, might enlarge and coalesce to form irregularly shaped plaques.surface might appear mamillated/ pseudopustular/ pseudovesicular due to edema.

Other possible features
* vesicles
* pustules
* vesiculobullous variant, which is most frequently associated with acute myelogenous
Leukemia, can progress to ulceration resembling superficial pyoderma gangrenosum (PG). In this form, there may be a single lesion or multiple, asymmetrically distributed lesions.
* ulcers - might appear like superficial PG.

  • targetoid appearance with central yellowish discoloration.
  • A facial erysipelas-like appearance.
  • giant cellulitis-like variant.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

How to diagnose sweet ?

A

Both of the major and two minor criteria ( out of 4) are needed for the diagnosis.

Major :

1) Abrupt onset of typical cutaneous lesions
2) histopathology consistent with Sweet syndrome

Minor :

  1. Preceded by one of the associated infections or vaccinations;
    accompanied by one of the associated malignancies or inflammatory
    disorders; associated with drug exposure or pregnancy
  2. Presence of fever and constitutional signs and symptoms
  3. Leukocytosis
  4. Excellent response to systemic corticosteroids
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Describe distribution pattern of sweet

A

The cutaneous eruption of Sweet syndrome favors the head, neck and upper extremities (including the dorsal aspect of the hands),

but can occur anywhere.

In true malignancy-associated cases, the lesions tend to have a more widespread distribution.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Are Oral lesions common ?

A

No, they are uncommon.

except in patients with hematologic disorders; initially they appear pseudopustular, and later ulcerate and appear as aphthae.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

What happens if sweet lesions are left untreated ?

A

The cutaneous eruption of Sweet syndrome usually resolves spontaneously within 5 - 12 weeks but recurs in up to 30% of patients.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

What happens if sweet lesions are left untreated ?

A

The cutaneous eruption of Sweet syndrome usually resolves spontaneously within 5 - 12 weeks but recurs in up to 30% of patients.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

What is a common prodrome in Sweet ?

A

An upper respiratory tract infection or flu-like illness frequently
precedes the development of the syndrome.

Fever occurs in 40-80% of patients and can be intermittent.

Extracutaneous involvement is also frequently seen (Fig. 26.4 ; Table 26.3).

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

SYSTEMIC MANIFESTATIONS OF SWEET SYNDROME

Common and less common

A

SYSTEMIC MANIFESTATIONS OF SWEET SYNDROME

Common (> 50%)
Fever
Leukocytosis

Less common (20-50%)
Arthralgias
Arthritis: asymmetric, non-erosive, sterile, favors knees and wrists
Myalgias
Ocular involvement: conjunctivitis, episcleritis, limbal nodules, iridocyclitis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

SYSTEMIC MANIFESTATIONS OF SWEET SYNDROME
Uncommon
Unusual / rare

A

Uncommon

Neutrophilic alveolitis: cough, dyspnea and pleurisy; radiographic findings
include interstitial infiltrates, nodules, pleural effusions

Multifocal sterile osteomyelitis, a subtype of SAPHO (see Table 26.18)

Renal involvement (e.g. mesangial glomerulonephritis): hematuria, 
proteinuria, renal insufficiency, acute renal failure 

‐——————–‐————-‐———————————–

Unusual/rare

Acute myositis
Hepatitis, pancreatitis, ileitis, colitis
Aseptic meningitis, encephalitis, bilateral sensorineural hearing loss
Other: aortitis, oral aphthae, pharyngitis, pharyngeal edema

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Workup of Sweet

A

CBC -look for leukocytosis and neutrophilia.
In hematologic malignancy or myelodysplasia, there may be a high or low white cell count, lymphocytosis or lymphopenia, and thrombocytosis or thrombocytopenia.

CRP , ESR - many times elevated

hepatic function test
Chemistry : look for renal function (possible renal involvement ), hepatic function tests, electrolytes

Hepatitis B C serology
CMV serology
HIV serology

Bacteriologic examinations and repeated cultures of wound swabs.

ANA ( due to collagen disease association )

Serum electrophoresis with immunofixation .

Urine light chains - Bence Jones

workup for an underlying solid tumor or lymphoproliferative disorder.

elevated serum levels of antineutrophil cytoplasmic antibody (ANCA) have been reported14, in particular pANCA or an atypical ANCA, there is no strong evidence that it is a serologic marker for this disease.

Biopsy :
marked edema in the upper dermis
Neutrophilic infiltrate
Fragmented nuclear “dust” of neutrophils (leukocytoclasia) in “top-heavy” fashion may be present
No LCV 

Skin biopsy for tissue culture
Periodic acid–Schiff and Ziehl-Neelsen stains for fungi and mycobacteria.

In bullous lesions include DIF. ( should be neg in sweet ).

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

SWEET SYNDROME - ASSOCIATED DISORDERS AND TRIGGERS

A

Infections
———-‐—–
Viruses: upper respiratory tract infections, cytomegalovirus, hepatitis B
virus, hepatitis C virus, HIV
Bacteria: Yersenia, streptococci
Mycobacteria: atypical mycobacteria, BCG vaccination, M. Tuberculosis, M.leprae
Fungi: dimorphic, including sporotrichosis and coccidiomycosis

Malignancies
—–‐—————-
Hematologic (10-20% ofcases*), in particular acute myelogenous leukemia
Myelodysplasia
Solid organ, predominantly the more common primary carcinomas

————–‐————-‐————–
Gastrointestinal disorders
—‐————-‐———————–
. Inflammatory bowel disease: Crohn , ulcerative colitis.

Drugs
‐———-
Antibiotics (e.g. minocycline, trimethoprim-sulfamethoxazole),
antihypertensives (e.g. furosemide, hydralazine), antineoplastics (e.g.
ipilimumab, pembrolizumab, FLT3 inhibitors, vemurafenib), colony
stimulating factors (e.g. G-CSF), contraceptives, immunosuppressant
medications (e.g. azathioprine), NSAIDs, retinoids (e.g. all-frans-retinoic
acid), bortezomid, lenalidomide

—‐————-‐———————–
Autoimmune disorders
—‐————-‐———————–
Autoimmune connective tissue diseases (e.g. systemic lupus
erythematosus SLE, rheumatoid arthritis, dermatomyositis, relapsing
polychondritis, Sjogren syndrome), autoimmune thyroid disease
Sarcoidosis
Behcet disease

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

SWEET SYNDROME - ASSOCIATED DISORDERS AND TRIGGERS

A

Infections
———-‐—–
Viruses: upper respiratory tract infections, cytomegalovirus, hepatitis B
virus, hepatitis C virus, HIV
Bacteria: Yersenia, streptococci
Mycobacteria: atypical mycobacteria, BCG vaccination, M. Tuberculosis, M.leprae
Fungi: dimorphic, including sporotrichosis and coccidiomycosis

Malignancies
—–‐—————-
Hematologic (10-20% ofcases*), in particular acute myelogenous leukemia
Myelodysplasia
Solid organ, predominantly the more common primary carcinomas

————–‐————-‐————–
Gastrointestinal disorders
—‐————-‐———————–
. Inflammatory bowel disease: Crohn , ulcerative colitis.

Drugs
‐———-
Antibiotics (e.g. minocycline, trimethoprim-sulfamethoxazole),
antihypertensives (e.g. furosemide, hydralazine), antineoplastics (e.g.
ipilimumab, pembrolizumab, FLT3 inhibitors, vemurafenib), colony
stimulating factors (e.g. G-CSF), contraceptives, immunosuppressant
medications (e.g. azathioprine), NSAIDs, retinoids (e.g. all-frans-retinoic
acid), bortezomid, lenalidomide

—‐————-‐———————–
Autoimmune disorders
—‐————-‐———————–
Autoimmune connective tissue diseases (e.g. systemic lupus
erythematosus SLE, rheumatoid arthritis, dermatomyositis, relapsing
polychondritis, Sjogren syndrome), autoimmune thyroid disease
Sarcoidosis
Behcet disease

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

characteristic histologic presentation of Sweet :

A

The characteristic histologic presentation is a diffuse nodular and perivascular neutrophilic infiltrate without evidence of vasculitis (Fig. 26.5), although occasionally leukocytoclastic vasculitis (LCV) can be observed. Leukocytoclasia with endothelial swelling, but without the fibrinoid necrosis that fulfills the criteria for LCV, is the usual finding.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

What are other histologic variants in sweet syndrome ?

A

Three histologic variants of Sweet syndrome

1) histiocytoid,
2) lymphocytic and
3) eosinophilic

The histiocytoid variant is characterized by a dermal, and sometimes subcutaneous, infiltrate composed of histiocyte-like immature myeloid cells. These cells have myeloperoxidase activity (Fig. 26.6 t© ) and must be distinguished from those of leukemia cutis.

The lymphocytic variant is often associated with, and sometimes precedes,
underlying myelodysplasia. More recently, an eosinophilic variant has been described.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

What are other histologic variants in sweet syndrome ?

A

Three histologic variants of Sweet syndrome

1) histiocytoid,
2) lymphocytic and
3) eosinophilic

The histiocytoid variant is characterized by a dermal, and sometimes subcutaneous, infiltrate composed of histiocyte-like immature myeloid cells. These cells have myeloperoxidase activity (Fig. 26.6 t© ) and must be distinguished from those of leukemia cutis.

The lymphocytic variant is often associated with, and sometimes precedes,
underlying myelodysplasia. More recently, an eosinophilic variant has been described.

15
Q

Which inherited autoinflammatory disease is in the differential diagnoses of sweet syndrome u?

A

Majeedsyndromeis characterized by recurrent episodes of fever and inflammation in the bones and skin. The two main features of this condition are chronic recurrent multifocal osteomyelitis (CRMO) andcongenitaldyserythropoieticanemia(CDA). CRMO causes recurrent episodes of pain and joint swelling which can lead to complications such as slow growth and the development of joint deformities calledcontractures. CDA involves a shortage ofred blood cellswhich can lead to fatigue (tiredness), weakness, pale skin, and shortness of breath. Most people with Majeed syndrome also develop inflammatory disorders of the skin, most often a condition known as Sweet syndrome. Majeed syndrome results frommutationsin theLPIN2gene. This condition isinheritedin anautosomal recessivepattern.[1]

This summary is not from Bolognia as there are no info in text.
Source : NIH /GARD website.

See table 45.7
Majeed syndrome skin findings : Edematous plaques, with a neutrophilic infiltrate within the dermis.

16
Q

What are NEUTROPHILIC DERMATOSES ASSOCIATED WITH HEMATOLOGIC MALIGNANCIES

A

Sweetsyndrome
Atypical (bullous) pyoderma gangrenosum
Neutrophilic eccrine hidradenitis

17
Q

Sweet syndrome treatment

A

most effective therapy for Sweet syndrome is oral prednisone (0.5–1.0 mg/kg/day) for 2–6 weeks.

some patients, prolonged low-dose prednisone for an additional 2–3 months may be necessary to suppress recurrences.

major alternative drugs are :

potassium iodide (900 mg/day; seeTable 100.6),
dapsone (100–200 mg/day),
colchicine (1.5 mg/day).

Note : while TNF inhibitors have been used to treat refractory Sweet syndrome, they can also be a cause of drug-induced Sweet syndrome.